Angelina Gangestad, MD
Obstetrics & Gynecology · Cleveland, OHNPI 1952334476
Payments from drug & device makers
Across 369 payments — averaging $2015.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$473K
- Medicines360$94K
- Sumitomo Pharma America, Inc.$63K
- Mitsubishi Tanabe Pharma Development America, Inc.$51K
- Abbott$44K
- Genbiopro, Inc.$17K
- plus $2K from 18 others
Across 1 payment — averaging $30,800 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genbiopro, Inc.$31K
What the payments were for
- Travel & lodging$54728%
- Food & beverage$1,43572%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 241 | $472,644 |
| Medicines360 | 35 | $93,731 |
| Sumitomo Pharma America, Inc. | 23 | $62,736 |
| Mitsubishi Tanabe Pharma Development America, Inc. | 3 | $51,330 |
| Abbott | 25 | $44,392 |
| Genbiopro, Inc. | 1 | $17,168 |
| Bayer | 8 | $966 |
| Astellas Pharma US Inc | 5 | $99 |
| Myovant Sciences Inc. | 1 | $79 |
| Organon | 5 | $77 |
| Aspira Women's Health Inc | 1 | $69 |
| Exeltis, USA Inc. | 4 | $68 |
| Meditrina | 1 | $45 |
| Sage Therapeutics, LLC | 2 | $41 |
| Hologic Sales And Service, LLC | 2 | $40 |
| Johnson & Johnson | 1 | $37 |
| Merck | 3 | $35 |
| Agile Therapeutics, Inc. | 1 | $20 |
| Mylan Pharmaceuticals Inc. | 1 | $17 |
| Evofem Biosciences, Inc. | 1 | $16 |
| Monaghan Medical Corporation | 2 | $15 |
| Duchesnay USA Incorporated | 1 | $13 |
| Coopersurgical, Inc. | 1 | $12 |
| Lupin Inc. | 1 | $11 |
How this compares
$743,661 in reported general payments places this provider in the 95th percentile of 1,376 obstetrics & gynecology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremproEstrogen,con/M-Progest Acet | 11 | $4,458 |
| Estradiol | 21 | $1,709 |
| Raloxifene Hcl | 15 | $624 |
| Trospium Chloride ErTrospium Chloride | 12 | $456 |
| Medroxyprogesterone Acetate | 11 | $429 |
| Fluconazole | 18 | $83 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Cleveland
- Jeffrey MangelCleveland$886K
- Linda-Dalal ShiberCleveland$152K
- Oluwatosin GojeCleveland$96K
- Amy ArmstrongCleveland$58K
- Lulu ZhaoCleveland$52K
- Linda BradleyCleveland$39K
- Julian PeskinCleveland$33K
- Gita GidwaniCleveland$31K
- Shirley BennettCleveland$25K
- Margaret RheeAkron$19.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.